TACSTD2 and breast carcinoma: Trop2 antibody has been constructed and tested by our former research, and human anti-Trop2 engineering antibody was used in immunohistochemistry (IHC) analysis [15] to investigate the inhibitory effectiveness of anti-Trop2 Fab antibody (Trop2Fab) in breast cancer [16].